Cargando…

Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1

INTRODUCTION. Sodium oxybate (SXB) was administered for the first time in 1979 in 16 patients with narcolepsy with cataplexy (NT1) that improved up to 20 months. AIMS. To evaluate the effect of SXB on daytime sleepiness and sleep architecture by video-polysomnography in a sample of 23 NT1 adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peraita-Adrados, Rosa, Bellón, José M., Lillo-Triguero, Laura, López-Esteban, Pilar, Medrano-Martínez, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Viguera Editores (Evidenze Group) 2023
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364034/ https://www.ncbi.nlm.nih.gov/pubmed/36631962 http://dx.doi.org/10.33588/rn.7602.2022315

Ejemplares similares

Sleep, Narcolepsy, and Sodium Oxybate
por: Mamelak, Mortimer
Publicado: (2022)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Efecto a largo plazo del oxibato de sodio en la somnolencia diurna y en la estructura del sueño en pacientes con narcolepsia de tipo 1
por: Peraita-Adrados, Rosa, et al.
Publicado: (2023)

Psychosis in Patients with Narcolepsy as an Adverse Effect of Sodium Oxybate
por: Sarkanen, Tomi, et al.
Publicado: (2014)

REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate
por: Antelmi, Elena, et al.
Publicado: (2021)

Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases
por: Martinez-Orozco, Francisco J., et al.
Publicado: (2022)

The Role of Sodium Oxybate in Idiopathic Hypersomnia: A Case Report Showing Improvement of Excessive Daytime Sleepiness and Reduced Symptoms
por: Vera Ricaurte, Michael, et al.
Publicado: (2023)

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
por: Rosenberg, Russell, et al.
Publicado: (2023)

Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing
por: Feldman, Neil T.
Publicado: (2009)

Off-label Sodium Oxybate in Childhood Narcolepsy: A Comprehensive Report
por: Miskoff, Jeffrey A, et al.
Publicado: (2018)

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
por: Schneider, Logan D, et al.
Publicado: (2023)

Sleep Architecture and Daytime Sleepiness in Patients with Erectile Dysfunction
por: Martynowicz, Helena, et al.
Publicado: (2023)

Circadian rhythm of daytime sleepiness in pediatric narcolepsy: A pilot study
por: Ouyang, Hui, et al.
Publicado: (2023)

A Case of Off-label Sodium Oxybate in an 11-Year-Old with Narcolepsy
por: Miskoff, Jeffrey A, et al.
Publicado: (2019)

Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1
por: Schinkelshoek, Mink S., et al.
Publicado: (2018)

Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy
por: Dubow, Jordan, et al.
Publicado: (2022)

O024 Sodium oxybate for refractory narcolepsy and idiopathic hypersomnia: clinical and employment outcomes
por: Hernest, A, et al.
Publicado: (2023)

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra, Jay T, et al.
Publicado: (2020)

Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series
por: Aguilar, Ana C., et al.
Publicado: (2019)

Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice
por: Drakatos, Panagis, et al.
Publicado: (2017)

Resolution of Sleepwalking Behavior after Initiation of Sodium Oxybate in a Patient with Narcolepsy Type 2
por: Hesselbacher, Sean, et al.
Publicado: (2018)

Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy
por: Chen, Cuiping, et al.
Publicado: (2020)

Psychomotor Vigilance Performance in Participants with Excessive Daytime Sleepiness in Obstructive Sleep Apnea or Narcolepsy Compared with SAFTE-FAST Model Predictions
por: Devine, Jaime K., et al.
Publicado: (2022)

Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment
por: Morse, Anne Marie, et al.
Publicado: (2023)

SUBJECTIVE SLEEP NEED AND DAYTIME SLEEPINESS IN ADOLESCENTS
por: Ferrari, Geraldo Jose, et al.
Publicado: (2019)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
por: Chien, Po-Yu, et al.
Publicado: (2022)

Pupillometric Assessment of Sleepiness in Narcolepsy
por: Prasad, Bharati, et al.
Publicado: (2011)

Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy
por: Bogan, Richard K, et al.
Publicado: (2021)

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018)

Longitudinal Change in Sleep and Daytime Sleepiness in Postpartum Women
por: Filtness, Ashleigh J., et al.
Publicado: (2014)

Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies
por: Romigi, A., et al.
Publicado: (2013)

Daytime Sleepiness and Sleep Inadequacy as Risk Factors for Dementia
por: Tsapanou, Angeliki, et al.
Publicado: (2015)

Simplified sleep resistance test for daytime sleepiness detection
por: Larrateguy, Luis Darío, et al.
Publicado: (2021)

Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
por: Meskill, Gerard J., et al.
Publicado: (2021)

Craniofacial Characteristics Related to Daytime Sleepiness Screened by the Paediatric Daytime Sleepiness Scale
por: Gu, Min, et al.
Publicado: (2015)

O029 Sleep architecture differs for individuals manifesting excessive daytime sleepiness with and without obstructive sleep apnea
por: Chen, X, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_76ooc575vljho8cq9bt83j2eq4